ARCH Venture Management, LLC
- SEC CIK
- 0001274403
- Latest filing
- Aug 14, 2026
RAPP holding history
Rapport Therapeutics, Inc. in every 13F filed by ARCH Venture Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RAPP overviewAll 13F holders of RAPPFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,728,738
- Value
- $155.4M
- % of portfolio
- 14.1%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,728,738 | $155.4M | 14.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 3,728,738 | $116.7M | 17.2% | 00.0% | Unchanged | Holders |
| Q4 2025 | 3,728,738 | $113.1M | 17.4% | 00.0% | Unchanged | Holders |
| Q3 2025 | 3,728,738 | $110.7M | 22.5% | 00.0% | Unchanged | Holders |
| Q2 2025 | 3,728,738 | $42.4M | 14.2% | 00.0% | Unchanged | Holders |
| Q1 2025 | 3,728,738 | $37.5M | 18.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,728,738 | $66.1M | 28.7% | 00.0% | Unchanged | Holders |
| Q3 2024 | 3,728,738 | $76.4M | 29.3% | 00.0% | Unchanged | Holders |
| Q2 2024 | 3,728,738 | $86.7M | 32.6% | +3,728,738 | New | Holders |